International Clinical Trial: A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519135) titled 'A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function' on April 2.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Pfizer

Condition: Healthy

Intervention: Drug: PF-08653944

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: April 15, 2026

Target Sample Size: 26

To know more, visit https://clinicaltrials.gov/study/NCT07519135

Published by HT Digital Content Services with permission from Health Daily D...